The Cooper Companies Inc (STU:CP60)
€ 95.65 -0.6 (-0.62%) Market Cap: 19.25 Bil Enterprise Value: 21.60 Bil PE Ratio: 57.71 PB Ratio: 2.60 GF Score: 91/100

Cooper Companies Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 14, 2023 / 06:40PM GMT
Release Date Price: €77.3 (+0.88%)
Steven Michael Lichtman
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

Hi, everyone. I'm Steve Lichtman, Medical Devices Analyst at Oppenheimer. Welcome back to the 33rd Annual Oppenheimer Healthcare Conference. I'm very happy to have with us up next CooperCompanies. So with us today is Brian Andrews, CFO, we're going to do this in a fireside chat format. If you do have any questions, please feed them into the chat box and I will make sure to get them over to Brian. But with that, Brian, thanks so much for joining us.

Questions & Answers

Steven Michael Lichtman
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

I thought we start really just on the CVI side of the business and your market outlook, as you look out over the next 5-plus years, what's Cooper's view on market growth and the key drivers that get you there?

Brian G. Andrews
Cooper Companies, Inc. - Executive VP, CFO & Treasurer

Yes. First of all, pleasure to be here. Thank you for having me

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot